TradesZ
Top 10 stocks to add now
← All stocks
CODX

CODX — CO-DIAGNOSTICS, INC.

CIK 1692415 · SEC EDGAR fundamentals

Latest 10-K filed March 31, 2026 · period ending December 31, 2024

Headline figures

Revenue

Top-line sales for the most-recent fiscal year

Net income
-$37.6M
-6.5% vs prior year

Profit after all expenses, taxes, interest

FY2025 · 10-K

EPS (diluted)
-$37.22
-3001.7% vs prior year

Net income per diluted share outstanding

FY2025 · 10-K

Op. cashflow
-$29.2M
-32.0% vs prior year

Cash actually generated by the business

FY2025 · 10-K

Balance sheet

Total assets
$63.6M

Everything the company owns

FY2025 · 10-K

Total liabilities
$9.7M

Everything the company owes

FY2025 · 10-K

Stockholders equity
$85.6M

Assets minus liabilities (book value)

FY2025 · 10-K

Long-term debt
$1.9M

Debt due more than 12 months out

FY2019 · 10-K

Read the source

All figures on this page were filed by CO-DIAGNOSTICS, INC. with the SEC and pulled directly from EDGAR's XBRL CompanyFacts API. Click below to view the latest annual report (10-K) in full.

Open latest 10-K on SEC EDGAR →

Data sources & methodology

All figures derive from official, public-domain government filings. Read our methodology for how we collect, process and score this data. See the methodology →

TZ Researched & published by TradesZ Research

Not investment advice. Figures sourced from the SEC's XBRL CompanyFacts API — public-domain federal records. Companies occasionally restate prior-year numbers; we show the latest filed value per fiscal year.